Research progress on the mechanistic role of TAF15 in multisystem inflammatory diseases and tumors

TATA-binding protein-associated factor 15 (TAF15), a key member of the FET family, is an RNA-binding protein extensively involved in RNA transcription, splicing, and transport. In recent years, a growing number of studies have shown that aberrant TAF15 expression is closely associated with the initiation and progression of various diseases, particularly exerting critical regulatory effects in inflammatory diseases and tumor progression. In inflammatory diseases, TAF15 not only contributes to the pathology of metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH) but also plays a significant role in multiple systemic inflammatory conditions, including pulpitis, knee osteoarthritis, sepsis-associated lung injury, and diabetic foot ulcers. This suggests its potential to drive disease progression by modulating inflammatory responses. In cancer, TAF15 displays even broader involvement. In digestive system tumors, it is closely linked to the pathogenesis of hepatocellular carcinoma, intrahepatic cholangiocarcinoma, gastric cancer, esophageal cancer, pancreatic cancer, and colorectal cancer. In respiratory system tumors, it participates in the malignant progression of lung cancer and nasopharyngeal carcinoma. Moreover, TAF15 is implicated in the development and progression of female-specific tumors (breast cancer, cervical cancer, and ovarian cancer), skin tumors (melanoma and cutaneous squamous cell carcinoma), and nervous system tumors (brain glioma). In summary, through complex molecular mechanisms, TAF15 exerts pro-inflammatory or pro-oncogenic effects in multisystem inflammatory diseases and tumors. While it shows potential as a candidate biomarker and therapeutic target, further in-depth investigation of its regulatory networks and extensive clinical validation are imperative before clinical translation.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2026-11-17
DOI
https://doi.org/10.3389/fimmu.2026.2009947
Primary Topic
RNA Research and Splicing
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Research progress on the mechanistic role of TAF15 in multisystem inflammatory diseases and tumors

Dingci Lu, Jie Mei, Jianying Ma, Lingling Wu et al.
2 links
Frontiers in Immunology
RNA Research and Splicing
article

Research progress on the mechanistic role of TAF15 in multisystem inflammatory diseases and tumors

Dingci Lu, Jie Mei, Jianying Ma, Lingling Wu, Yahui Chen, Jiale Liu, Tao Wang, Yan Yi
article en

Abstract

TATA-binding protein-associated factor 15 (TAF15), a key member of the FET family, is an RNA-binding protein extensively involved in RNA transcription, splicing, and transport. In recent years, a growing number of studies have shown that aberrant TAF15 expression is closely associated with the initiation and progression of various diseases, particularly exerting critical regulatory effects in inflammatory diseases and tumor progression. In inflammatory diseases, TAF15 not only contributes to the pathology of metabolic dysfunction-associated steatohepatitis (MASH, formerly known as NASH) but also plays a significant role in multiple systemic inflammatory conditions, including pulpitis, knee osteoarthritis, sepsis-associated lung injury, and diabetic foot ulcers. This suggests its potential to drive disease progression by modulating inflammatory responses. In cancer, TAF15 displays even broader involvement. In digestive system tumors, it is closely linked to the pathogenesis of hepatocellular carcinoma, intrahepatic cholangiocarcinoma, gastric cancer, esophageal cancer, pancreatic cancer, and colorectal cancer. In respiratory system tumors, it participates in the malignant progression of lung cancer and nasopharyngeal carcinoma. Moreover, TAF15 is implicated in the development and progression of female-specific tumors (breast cancer, cervical cancer, and ovarian cancer), skin tumors (melanoma and cutaneous squamous cell carcinoma), and nervous system tumors (brain glioma). In summary, through complex molecular mechanisms, TAF15 exerts pro-inflammatory or pro-oncogenic effects in multisystem inflammatory diseases and tumors. While it shows potential as a candidate biomarker and therapeutic target, further in-depth investigation of its regulatory networks and extensive clinical validation are imperative before clinical translation.

Frontiers in ImmunologyVol. 17
Yangtze University (CN), Hubei University of Chinese Medicine (CN), Nanyang Institute of Technology (CN), The First People's Hospital of Tianmen (CN), The Eighth Hospital of Xi'an (CN), Hubei College of Chinese Medicine (CN)
Good health and well-being
RNA Research and Splicing
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon